FdaApplication
NDA 217677
Identifiers
- fda_app_no: NDA217677
Properties
| Property | Value |
|---|---|
| applicant_name | SPRINGWORKS THERAPEUTICS INC |
| application_type | NDA |
| approval_date | 2023-11-27 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| OGSIVEO | NIROGACESTAT HYDROBROMIDE | EQ 150MG BASE | TABLET;ORAL |
| OGSIVEO | NIROGACESTAT HYDROBROMIDE | EQ 50MG BASE | TABLET;ORAL |
| OGSIVEO | NIROGACESTAT HYDROBROMIDE | EQ 100MG BASE | TABLET;ORAL |
3 products